Align Technology NASDAQ: ALGN expects its iTero scanner business to return to revenue growth in 2027 after pricing discounts and product mix contributed to a reduction in its 2026 sales outlook, executives said at the Jefferies Global Healthcare Conference in London.
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Paul J. Clancy, a biopharmaceutical executive and former Executive Vice President and Chief Financial Officer of A.
Align Technology, Inc. (ALGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Align Technology's Invisalign expansion, strategic alliances and strong stock gains support its prospects, but currency volatility and competition pose risks.
Allworth Financial LP increased its position in shares of Align Technology, Inc. (NASDAQ: ALGN) by 3,306.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 115,575 shares of the medical equipment provider's stock after buying an additional 112,182 shares during the period. Allworth Financial
AlphaCore Capital LLC lifted its position in Align Technology, Inc. (NASDAQ: ALGN) by 1,170.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,586 shares of the medical equipment provider's stock after purchasing an additional 22,651 shares during the quarter.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at the following financial conference. The presentation will be webcast live via the Investor Relations section of Align's website at ht.
TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced recognition in the 2026 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the qual.
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it has entered into a new accelerated stock repurchase agreement (“ASR”) with Goldman Sachs & Co. LLC (“Goldman Sachs”), to repurchase $270 million of Align's common s.
Align Technology remains the global leader in clear aligners but faces intensifying competition and declining pricing power, especially in North America. ALGN's US market is saturated, with falling shipments, utilization, and revenue per case; international growth is now the primary driver. Gross margins and brand strength are under pressure, with competitors gaining share through lower costs and improved aesthetics.